Tue, April 30, 2024
Mon, April 29, 2024
Fri, April 26, 2024

Kyle Mikson Maintained (TXG) at Strong Buy with Decreased Target to $50 on, Apr 29th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-50-on-apr-29th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Kyle Mikson of Canaccord Genuity, Maintained "10x Genomics, Inc." (TXG) at Strong Buy with Decreased Target from $65 to $50 on, Apr 29th, 2024.

Kyle has made no other calls on TXG in the last 4 months.



There are 3 other peers that have a rating on TXG. Out of the 3 peers that are also analyzing TXG, 0 agree with Kyle's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Kyle


  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $55 on, Thursday, April 18th, 2024
  • Luke Sergott of "Barclays" Maintained at Buy with Decreased Target to $45 on, Wednesday, April 10th, 2024
  • Daniel Arias of "Stifel" Maintained at Strong Buy with Decreased Target to $63 on, Friday, February 16th, 2024

Publication Contributing Sources